Acceleron Pharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2004-01-01
- Employees
- 312
- Market Cap
- -
- Website
- http://acceleronpharma.com
BMS Announces Positive Reblozyl Phase 3 Results for MDS
Bristol Myers Squibb has reported positive phase 3 trial results for Reblozyl, showing significant improvement in red blood cell transfusion independence for patients with myelodyplastic syndromes (MDS).
Merck Halts Phase 3 HYPERION Trial of Winrevair Early After Positive ZENITH Results
• Merck's Phase 3 HYPERION trial of Winrevair (sotatercept) for pulmonary arterial hypertension (PAH) is stopped early due to positive results from the ZENITH trial.
• The decision, made with the FDA and a steering committee, allows all HYPERION participants access to Winrevair in the SOTERIA extension study.
• Winrevair, already approved in the U.S. and 38 countries, showed significant efficacy in the STELLAR and ZENITH trials, leading to the HYPERION halt.
• HYPERION findings will be available later this year, adding to the growing evidence supporting Winrevair's role in PAH treatment.
© Copyright 2025. All Rights Reserved by MedPath